Point of care upconversion nanoparticles-based lateral flow assay quantifying myoglobin in clinical human blood samples

[1]  R. D. de Winter,et al.  Value of myoglobin, troponin T, and CK-MBmass in ruling out an acute myocardial infarction in the emergency room. , 1995, Circulation.

[2]  P. Venge,et al.  Lateral flow immunoassay using Europium (III) chelate microparticles and time-resolved fluorescence for eosinophils and neutrophils in whole blood. , 2007, Clinical chemistry.

[3]  Zhengquan Li,et al.  An efficient and user-friendly method for the synthesis of hexagonal-phase NaYF4:Yb, Er/Tm nanocrystals with controllable shape and upconversion fluorescence , 2008, Nanotechnology.

[4]  D. Armbruster,et al.  Limit of blank, limit of detection and limit of quantitation. , 2008, The Clinical biochemist. Reviews.

[5]  Jiumin Yang,et al.  Quantum dot-based immunochromatography test strip for rapid, quantitative and sensitive detection of alpha fetoprotein. , 2011, Biosensors & bioelectronics.

[6]  Hongju Mao,et al.  Simultaneous detection of high-sensitivity cardiac troponin I and myoglobin by modified sandwich lateral flow immunoassay: proof of principle. , 2011, Clinical chemistry.

[7]  Annalisa D'Andrea,et al.  Lateral flow assay with near-infrared dye for multiplex detection. , 2013, Clinical chemistry.

[8]  Jie Shen,et al.  Stem Cell Labeling using Polyethylenimine Conjugated (α-NaYbF4:Tm3+)/CaF2 Upconversion Nanoparticles , 2013, Theranostics.

[9]  Andrew Wang,et al.  Immunochromatographic Assay for Ultrasensitive Detection of Aflatoxin B1 in Maize by Highly Luminescent Quantum Dot Beads , 2014, ACS applied materials & interfaces.

[10]  P. Prasad,et al.  Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics , 2014, Chemical reviews.

[11]  Weisheng Guo,et al.  Rapid and quantitative detection of prostate specific antigen with a quantum dot nanobeads-based immunochromatography test strip. , 2014, ACS applied materials & interfaces.

[12]  Mingyuan Gao,et al.  Upconversion luminescence nanoparticles-based lateral flow immunochromatographic assay for cephalexin detection , 2014 .

[13]  E. Choi,et al.  Point‐of‐Care Fluorescence Immunoassay for Cardiac Panel Biomarkers , 2014, Journal of clinical laboratory analysis.

[14]  Dayong Jin,et al.  Controlling upconversion nanocrystals for emerging applications. , 2015, Nature nanotechnology.

[15]  Wang Chunying,et al.  Simultaneous quantitative detection of multiple tumor markers with a rapid and sensitive multicolor quantum dots based immunochromatographic test strip. , 2015 .

[16]  M. Montagnana,et al.  An historical approach to the diagnostic biomarkers of acute coronary syndrome. , 2016, Annals of translational medicine.

[17]  Jie Hu,et al.  Improved sensitivity of lateral flow assay using paper-based sample concentration technique. , 2016, Talanta.

[18]  Noah D Bronstein,et al.  Precise Tuning of Surface Quenching for Luminescence Enhancement in Core-Shell Lanthanide-Doped Nanocrystals. , 2016, Nano letters.

[19]  Guanying Chen,et al.  Tunable Narrow Band Emissions from Dye-Sensitized Core/Shell/Shell Nanocrystals in the Second Near-Infrared Biological Window. , 2016, Journal of the American Chemical Society.

[20]  Xiaomin Liu,et al.  Employing shells to eliminate concentration quenching in photonic upconversion nanostructure. , 2017, Nanoscale.

[21]  Jeffrey L. Anderson,et al.  Acute Myocardial Infarction. , 2017, The New England journal of medicine.

[22]  S. Wilhelm,et al.  Perspectives for Upconverting Nanoparticles. , 2017, ACS nano.

[23]  Wei Feng,et al.  Revisiting the optimized doping ratio in core/shell nanostructured upconversion particles. , 2017, Nanoscale.

[24]  Michael Christ,et al.  Analytical evaluation of a new point of care system for measuring cardiac Troponin I. , 2017, Clinical biochemistry.

[25]  Dan J Stein,et al.  Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.